mk 287 has been researched along with Sensitivity and Specificity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberts, AW; Bach, TJ; Chabala, JC; Hwang, SB; Lam, MH; Luell, S; MacIntyre, DE; Meuer, R; Sahoo, SP; Szalkowski, DM | 1 |
1 other study(ies) available for mk 287 and Sensitivity and Specificity
Article | Year |
---|---|
MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Topics: Administration, Oral; Animals; Binding, Competitive; Blood Platelets; Bronchoconstriction; Furans; Guinea Pigs; Humans; Kinetics; Lung; Membranes; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sensitivity and Specificity; Tritium | 1993 |